The Parkinson's Horizon Boek Geneeskunde en Verpleging

Prijzen vanaf
15,00

Gesponsorde links

VERGELIJK ALLE AANBIEDERS (3)

Beschrijving

Bol Every week brings another Parkinson's "breakthrough." This book teaches you how to tell which ones could actually reach your neurologist's office, and which will never leave the laboratory. Written by a patient living with young-onset Parkinson's since thirty-six, The Parkinson's Horizon is not a list of cures. It is a sorting machine. By the last chapter you will be able to pick up almost any headline about stem cells, gene therapy, focused ultrasound, deep brain stimulation, new drug pumps or a drug that "slows the disease" and place it, calmly, where the evidence puts it: established, emerging, or experimental. What you will learn: - The evidence staircase: what Phase 1, 2 and 3 really mean, and why "worked in mice" is a location, not a promise- Five questions that fit in your pocket and take apart any trial claim in two minutes- Why "managing symptoms" and "slowing the disease" are two different jobs, and why no approved drug does the second one yet- Focused ultrasound, adaptive deep brain stimulation, levodopa and apomorphine infusion pumps: what they treat, what they cannot, and who they suit- Gene therapy and stem cells: the real research, the Japanese conditional approval, and how to spot a clinic that sells hope for a fee- Should you join a clinical trial? A one-page fit checklist to fill in before you say yes- The eight questions that change a fifteen-minute neurology appointment Includes "Where Things Stand: September 2026", a dated appendix that names the actual products and trials, labeled established, emerging or closed: bilateral focused ultrasound, BrainSense adaptive DBS, Vyalev and Onapgo, Amchepry, bemdaneprocel, prasinezumab, AB-1005, ambroxol, exenatide, BIIB122 and more, with 28 checked sources. No miracle promised. No drug recommended. What you get instead is steadiness: the habit of sorting a story into its drawer before you let it anywhere near your mood, and the exact words to open it with the one person whose answer applies to you. For people with Parkinson's, their families, and anyone tired of swinging between false hope and dread every time the news says "cure." This book provides general educational information and is not a substitute for medical advice. Always consult your neurologist before changing treatment.

Vergelijk aanbieders (3)

Gesponsorde links · Sommige shops betalen ons een vergoeding

Sorteren op:

€ 15,00 € 2,99 verzendkosten Totaal € 17,99

€ 15,50 Gratis verzending

€ 15,50 Gratis verzending

Beschrijving (1)

Every week brings another Parkinson's "breakthrough." This book teaches you how to tell which ones could actually reach your neurologist's office, and which will never leave the laboratory. Written by a patient living with young-onset Parkinson's since thirty-six, The Parkinson's Horizon is not a list of cures. It is a sorting machine. By the last chapter you will be able to pick up almost any headline about stem cells, gene therapy, focused ultrasound, deep brain stimulation, new drug pumps or a drug that "slows the disease" and place it, calmly, where the evidence puts it: established, emerging, or experimental. What you will learn: - The evidence staircase: what Phase 1, 2 and 3 really mean, and why "worked in mice" is a location, not a promise- Five questions that fit in your pocket and take apart any trial claim in two minutes- Why "managing symptoms" and "slowing the disease" are two different jobs, and why no approved drug does the second one yet- Focused ultrasound, adaptive deep brain stimulation, levodopa and apomorphine infusion pumps: what they treat, what they cannot, and who they suit- Gene therapy and stem cells: the real research, the Japanese conditional approval, and how to spot a clinic that sells hope for a fee- Should you join a clinical trial? A one-page fit checklist to fill in before you say yes- The eight questions that change a fifteen-minute neurology appointment Includes "Where Things Stand: September 2026", a dated appendix that names the actual products and trials, labeled established, emerging or closed: bilateral focused ultrasound, BrainSense adaptive DBS, Vyalev and Onapgo, Amchepry, bemdaneprocel, prasinezumab, AB-1005, ambroxol, exenatide, BIIB122 and more, with 28 checked sources. No miracle promised. No drug recommended. What you get instead is steadiness: the habit of sorting a story into its drawer before you let it anywhere near your mood, and the exact words to open it with the one person whose answer applies to you. For people with Parkinson's, their families, and anyone tired of swinging between false hope and dread every time the news says "cure." This book provides general educational information and is not a substitute for medical advice. Always consult your neurologist before changing treatment.


Productspecificaties

Merk Independently Published
EAN
  • 9798172065248
Maat


Prijshistorie

* Prijshistorie bevat geen data van Amazon, Amazon Marketplace.

Prijzen voor het laatst bijgewerkt op:

Uitgelichte Keuze
15,00
Naar shop